GPCR antagonism via rewiring of receptor trafficking and degradation
A novel strategy for functional GPCR antagonism via bispecific antibody-mediated endocytosis and lysosomal degradation is reported via bispecific antibody-mediated endocytosis and lysosomal degradation, establishing induced endocytosis and rewiring protein trafficking as a new paradigm for therapeutic GPCR modulation.